as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹1,478.3
Change
+41.7 (2.9%)
Open
₹1,436.6
Prev. Close
₹1,436.6
Day High
₹1,485.5
Day Low
₹1,432.7
Volume Analysis
Traded
282,387
Delivered
183,933
Delivery %
65.14%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (22.0%)
Weaknesses (0)
No signal for this stock
Opportunities (2)
- •Strong 3-year EPS growth (19.4%)
- •Strong 3-year revenue growth (17.6%)
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,551.1 | ₹1,518.3 | ₹1,498.3 | ₹1,465.5 | ₹1,445.5 | ₹1,412.7 | ₹1,392.7 |
| Fibonacci | ₹1,518.3 | ₹1,498.13 | ₹1,485.67 | ₹1,465.5 | ₹1,445.33 | ₹1,432.87 | ₹1,412.7 |
| Camarilla | ₹1,492.82 | ₹1,487.98 | ₹1,483.14 | ₹1,465.5 | ₹1,473.46 | ₹1,468.62 | ₹1,463.78 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+24.03%
1 Week
+2.68%
1 Month
+19.95%
3 Months
+4.87%
6 Months
+19.4%
1 Year
+21.86%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹273.84
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
12.43%
Net margin 12.13% × asset turnover 0.67x × equity multiplier 1.53x
Company Overview
Sector
Healthcare
Market Cap
₹38,864 Cr
P/E (TTM)
60.0
ROE
15.2%
Book Value
₹161.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Global Health Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 69/100. The strongest factor is Financial Strength (99/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
69/100 — GoodData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 80.7% CAGR over last 5 years
- −Stock is trading at 8.96 times its book value
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
Investor Presentation for the Analyst/Investors Meet .
Global Health schedules one-on-one investor meetings on November 19-20, 2026 with several global asset managers.
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 844 | 836 | 809 | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 | 1,469 |
| Expenses + | 631 | 620 | 629 | 675 | 728 | 706 | 707 | 784 | 868 | 904 | 915 | 1,017 | 1,099 |
| Operating Profit | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 | 370 |
| OPM % | 25.0% | 26.0% | 22.0% | 22.0% | 24.0% | 25.0% | 24.0% | 24.0% | 21.0% | 19.0% | 21.0% | 22.0% | 25.0% |
| Other Income + | 21 | 18 | 27 | 22 | 18 | 16 | -27 | 20 | 36 | -15 | 37 | 22 | 24 |
| Interest | 20 | 18 | 18 | 18 | 16 | 16 | 15 | 14 | 17 | 22 | 27 | 27 | 28 |
| Depreciation | 43 | 44 | 45 | 47 | 49 | 48 | 49 | 45 | 50 | 61 | 67 | 69 | 71 |
| Profit before tax | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 | 295 |
| Tax % | 27.0% | 28.0% | 11.0% | 26.0% | 28.0% | 24.0% | 24.0% | 24.0% | 21.0% | 21.0% | 24.0% | 26.0% | 26.0% |
| Net Profit + | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 | 219 |
| EPS in Rs | 5 | 5 | 5 | 4 | 5 | 5 | 4 | 6 | 6 | 4 | 5 | 6 | 8 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 24 | 20 | 14 | 10 | 13 | 13 | 15 | 20 | 15 | 19 | 24 | 26 | 34 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,382 | 1,343 | 1,456 | 1,500 | 1,447 | 2,167 | 2,710 | 3,275 | 3,692 | 4,410 | 5,053 |
| Expenses + | 1,081 | 1,218 | 1,283 | 1,309 | 1,250 | 1,709 | 2,073 | 2,466 | 2,806 | 3,480 | 3,935 |
| Operating Profit | 301 | 125 | 172 | 192 | 197 | 458 | 637 | 809 | 886 | 930 | 1,118 |
| OPM % | 22.0% | 9.0% | 12.0% | 13.0% | 14.0% | 21.0% | 24.0% | 25.0% | 24.0% | 21.0% | 22.0% |
| Other Income + | 45 | 49 | 50 | 44 | 31 | 39 | 49 | 75 | 29 | 98 | 68 |
| Interest | 14 | 28 | 38 | 57 | 73 | 86 | 86 | 84 | 74 | 90 | 103 |
| Depreciation | 70 | 86 | 102 | 115 | 123 | 130 | 150 | 173 | 194 | 223 | 267 |
| Profit before tax | 262 | 60 | 83 | 64 | 32 | 281 | 449 | 627 | 647 | 715 | 815 |
| Tax % | 35.0% | 45.0% | 38.0% | 43.0% | 11.0% | 30.0% | 27.0% | 24.0% | 26.0% | 23.0% | — |
| Net Profit + | 170 | 33 | 51 | 36 | 29 | 196 | 326 | 478 | 481 | 554 | 613 |
| EPS in Rs | 7 | 1 | 2 | 1 | 1 | 8 | 12 | 18 | 18 | 21 | 23 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.0% | — |
| Sales growth | — | — | 8 | 3 | -4 | 50 | 25 | 21 | 13 | 19 | 26 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 976 | 1,136 | 1,246 | 1,300 | 1,333 | 1,565 | 2,375 | 2,852 | 3,333 | 3,908 | 4,270 |
| Borrowings + | 165 | 456 | 787 | 929 | 931 | 1,109 | 1,122 | 802 | 718 | 1,190 | 1,353 |
| Other Liabilities + | 295 | 343 | 347 | 388 | 380 | 421 | 547 | 572 | 662 | 753 | 930 |
| Total Liabilities | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 | 6,606 |
| Fixed Assets + | 914 | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 | 2,236 | 2,514 | 3,795 | 3,957 |
| CWIP | 12 | 317 | 666 | 382 | 464 | 439 | 327 | 388 | 533 | 132 | 207 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 |
| Other Assets + | 559 | 573 | 570 | 581 | 615 | 930 | 1,720 | 1,656 | 1,716 | 1,975 | 2,440 |
| Total Assets | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 | 6,606 |
| Equity Capital | 48 | 48 | 49 | 49 | 50 | 51 | 54 | 54 | 54 | 54 | 54 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 228 | 63 | 166 | 175 | 242 | 311 | 645 | 612 | 624 | 714 |
| Cash from Investing Activity + | -241 | -69 | -249 | -87 | -239 | -421 | -342 | -441 | -721 | -1,089 |
| Cash from Financing Activity + | -7 | 9 | 97 | -1 | -81 | 160 | 346 | -514 | -97 | 272 |
| Net Cash Flow | -20 | 3 | 14 | 87 | -78 | 50 | 648 | -343 | -194 | -103 |
| Free Cash Flow | 71 | -81 | -133 | -13 | 100 | 38 | 409 | 335 | 110 | -123 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 108 | 93 | 135 | 121 | 131 | 89 | 118 | 98 | 89 | 90 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Others | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.06% | 0.06% | 0.06% | 0.08% | 0.09% | 0.12% |
| Public | 44.45% | 44.6% | 43.44% | 43.64% | 43.98% | 43.28% | 43.19% | 42.56% | 42.41% | 42.01% | 40.55% | 39.96% |
| Promoters | 33.05% | 33.04% | 33.04% | 33.04% | 33.03% | 33.03% | 33.01% | 33.01% | 33.01% | 33.01% | 33.0% | 33.0% |
| FII | 11.36% | 12.1% | 12.94% | 12.21% | 12.48% | 11.76% | 11.54% | 11.41% | 10.54% | 10.15% | 9.46% | 9.92% |
| DII | 11.15% | 10.25% | 10.57% | 11.11% | 10.51% | 11.93% | 12.2% | 12.97% | 13.99% | 14.76% | 16.89% | 17.01% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Global Health Limited (this stock) | 38,864 | 60.0 | 8.97 | 15.2% |
| Sai Life Sciences Limited | 38,018 | 99.5 | 14.08 | 15.4% |
| Narayana Hrudayalaya Ltd. | 37,889 | 41.8 | 7.57 | 20.5% |
| Ajanta Pharma Limited | 41,393 | 32.8 | 8.51 | 27.1% |
| Dr. Lal Path Labs Ltd. | 33,582 | 55.5 | 12.2 | 22.3% |
| Emcure Pharmaceuticals L | 44,370 | 39.9 | 8.29 | 20.1% |
| Wockhardt Limited | 32,944 | 82.4 | 6.39 | 6.11% |
Which Mutual Funds Hold Global Health Limited?
Frequently Asked Questions about Global Health Limited
Global Health Limited (MEDANTA) closed at ₹1,478.3 on NSE on 19 November 2026, up 41.7 (2.9%) from the previous close.
Global Health Limited trades on the NSE (National Stock Exchange of India) under the symbol MEDANTA.
Global Health Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 60.0.
Global Health Limited has a dividend yield of 0.03%.
Global Health Limited's 52-week high is ₹1,544.0 and its 52-week low is ₹955.0.
Global Health Limited has a market capitalisation of ₹38,864 crore.
Global Health Limited has a TopFund Quality Score of 69/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Global Health Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.